EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders

George E Zakynthinos iD, Vasiliki Tsolaki iD, Evangelos Oikonomou iD, Manolis Vavouranakis, Gerasimos Siasos, Epaminondas Zakynthinos

Journal of Personalized Medicine · 28.08.2023 · 13 (9) · 1323

DOI: 10.3390/jpm13091323 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 28.08.2023. Verfasst von George E Zakynthinos und 5 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Cardiology, "Sotiria" Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity, hypertension, insulin resistance, and dyslipidemia are all clusters of an entity called “Metabolic Syndrome”. The global trends of this syndrome’s incidence/prevalence continue to increase reciprocally, converting it into a massive epidemic problem in the medical community. Observing the risk factors of atrial fibrillation, a medical condition that is also converted to a scourge, almost all parts of the metabolic syndrome are encountered. In addition, several studies demonstrated a robust correlation between metabolic syndrome and the occurrence of atrial fibrillation. For atrial fibrillation to develop, a combination of the appropriate substrate and a trigger point is necessary. The metabolic syndrome affects the left atrium in a multifactorial way, leading to atrial remodeling, thus providing both the substrate and provoking the trigger needed, which possibly plays a substantial role in the progression of atrial fibrillation. Due to the remodeling, treatment of atrial fibrillation may culminate in pernicious sequelae, such as repeated catheter ablation procedures. A holistic approach of the patient, with simultaneous treatment of both entities, is suggested in order to ensure better outcomes for the patients.

Schlagwörter

Stichwörter der Autor:innen

atrial fibrillationcardiometabolic syndromeinsulin resistancemetabolic syndromeobesity

Autor:innen und Institutionen

  • 3rd Department of Cardiology, "Sotiria" Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Critical Care Department, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, Mezourlo, 41335 Larissa, Greece.
  • Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

ORCID-Profile: George E Zakynthinos, Vasiliki Tsolaki, Evangelos Oikonomou

Zitieren

APA

Zakynthinos, G. E., Tsolaki, V., Oikonomou, E., Vavouranakis, M., Siasos, G., & Zakynthinos, E. (2023). Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders. Journal of Personalized Medicine, 13(9), 1323. https://doi.org/10.3390/jpm13091323

Vancouver

Zakynthinos GE, Tsolaki V, Oikonomou E, Vavouranakis M, Siasos G, Zakynthinos E. Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders. Journal of Personalized Medicine. 2023;13(9):1323. doi:10.3390/jpm13091323

BibTeX
@article{Zakynthinos2023,
  author = {Zakynthinos, George E and Tsolaki, Vasiliki and Oikonomou, Evangelos and Vavouranakis, Manolis and Siasos, Gerasimos and Zakynthinos, Epaminondas},
  title = {Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders},
  journal = {Journal of Personalized Medicine},
  year = {2023},
  volume = {13},
  number = {9},
  pages = {1323},
  doi = {10.3390/jpm13091323}
}
Kostenlos starten →